[P1] Poster Session Core Time (奇数番号)

[P1-55] Validation of AI-predicted Dengue virus-specific HLA class I epitopes for vaccine development.

*SHARA BAKYTBEK^1,2,3, Farzaneh Valanezhad^1,2,3, Ayako Hyuga^1,2,3, Shin-Ichi Inoue^2,4, Yui Katsuyuki⁵, Shusaku Mizukami^3,6, Risa Nakamura^1,2,3, Kazuhide Onoguchi⁷, Sebastian Kapell^8,9, Kouichi Morita^3,10, Shinjiro Hamano^1,2,3 (1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. Department of Molecular Microbiology and Immunology, Division of Immunology, Nagasaki University, Nagasaki (Japan), 5. SHIONOGI Global Infectious Diseases Division Institute of Tropical Medicine, Nagasaki University, Nagasaki (Japan), 6. Department of Immune Regulations, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 7. AI Drug Development Division, NEC Corporation, Tokyo (Japan), 8. Department of Vaccine Informatics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 9. NEC OncoImmunity AS, Ullernchausseen 64/66, 0379, Oslo (Norway), 10. Department of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan))